Dr. Samuel Mehr
Claim this profileNebraska Cancer Specialists
Studies Neuroendocrine Tumors
Studies Pancreatic Neuroendocrine Tumors
4 reported clinical trials
6 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
Stage III
2Pancreatic Neuroendocrine Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Samuel Mehr is currently running
Targeted Alpha-Particle Therapy
for Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Recruiting1 award Phase 1 & 213 criteria
Targeted Alpha-Particle Therapy
for Melanoma
In this first-in human, phase I/IIa study, the safety and efficacy of [212Pb]VMT01, an alpha-particle emitting therapeutic agent targeted to melanocortin sub-type 1 receptor (MC1R) is being evaluated in patients with unresectable and metastatic melanoma.
Recruiting1 award Phase 1 & 213 criteria
More about Samuel Mehr
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Samuel Mehr has experience with
- RYZ101
- Lutathera
- Long-acting Octreotide
- High Dose Long-acting Octreotide
- [212Pb]VMT01
- [212Pb]VMT-α-NET
Breakdown of trials Samuel Mehr has run
Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumors
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samuel Mehr specialize in?
Samuel Mehr focuses on Neuroendocrine Tumors and Pancreatic Neuroendocrine Tumors. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Samuel Mehr currently recruiting for clinical trials?
Yes, Samuel Mehr is currently recruiting for 2 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Samuel Mehr has studied deeply?
Yes, Samuel Mehr has studied treatments such as RYZ101, Lutathera, long-acting octreotide.
What is the best way to schedule an appointment with Samuel Mehr?
Apply for one of the trials that Samuel Mehr is conducting.
What is the office address of Samuel Mehr?
The office of Samuel Mehr is located at: Nebraska Cancer Specialists, Omaha, Nebraska 68130 United States. This is the address for their practice at the Nebraska Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.